Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized cros...

por Scholtes, Rosalie A., Mosterd, Charlotte M., Hesp, Anne C., Smits, Mark M., Heerspink, Hiddo J. L., van Raalte, Daniël H.
Publicado 2022

Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using para-Aminohippuric Acid, With a Focus on SGLT2 Inhibitors

por Scholtes, Rosalie A., Nguyen, Isabel T.N., van Bommel, Erik J.M., Willekes, Nel, van Nieuwenhuijzen, Melanie, van Raalte, Daniël H., Joles, Jaap A.
Publicado 2020

Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors

por Scholtes, Rosalie A., van Baar, Michaël J. B., Kok, Megan D., Bjornstad, Petter, Cherney, David Z. I., Joles, Jaap A., van Raalte, Daniël H.
Publicado 2021

The effects of dapagliflozin on cardio‐renal risk factors in patients with type 2 diabetes with or without renin‐angiotensin system inhibitor treatment: a post hoc analysis

por Scholtes, Rosalie A., van Raalte, Daniël H., Correa‐Rotter, Ricardo, Toto, Robert D., Heerspink, Hiddo J. L., Cain, Valerie, Sjöström, C. David, Sartipy, Peter, Stefánsson, Bergur V.
Publicado 2019

Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes

por van der Hoek, Sjoukje, Koomen, Jeroen V., van Bommel, Erik J. M., Mosterd, Charlotte M., Scholtes, Rosalie A., Hesp, Anne C., Stevens, Jasper, van Raalte, Daniel H., Heerspink, Hiddo J. L.
Publicado 2023

Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT...

por Scholtes, Rosalie A., Muskiet, Marcel H.A., van Baar, Michiel J.B., Hesp, Anne C., Greasley, Peter J., Karlsson, Cecilia, Hammarstedt, Ann, Arya, Niki, van Raalte, Daniël H., Heerspink, Hiddo J.L.
Publicado 2021

The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet...

por Scholtes, Rosalie A., Muskiet, Marcel H.A., van Baar, Michiel J.B., Hesp, Anne C., Greasley, Peter J., Hammarstedt, Ann, Karlsson, Cecilia, Hallow, Karen M., Danser, A.H. Jan, Heerspink, Hiddo J.L., van Raalte, Daniël H.
Publicado 2022

Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND

por Sen, Taha, Scholtes, Rosalie, Greasley, Peter J., Cherney, David Z. I., Dekkers, Claire C. J., Vervloet, Marc, Danser, Alexander H. J., Barbour, Sean J., Karlsson, Cecilia, Hammarstedt, Ann, Li, Qiang, Laverman, Gozewijn D., Bjornstad, Petter, van Raalte, Daniel H., Heerspink, Hiddo J. L.
Publicado 2022